In the latest trading session,, 0.57 million Rockwell Medical Inc (NASDAQ:RMTI) shares changed hands as the company’s beta touched 1.38. With the company’s most recent per share price at $3.75 changing hands around $0.22 or 6.20% at last look, the market valuation stands at $116.33M. RMTI’s last price was a premium, traded about 4.27% off its 52-week high of $3.59. The share price had its 52-week low at $1.16, which suggests the last value was 69.07% up since then. When we look at Rockwell Medical Inc’s average trading volume, we note the 10-day average is 0.6 million shares, with the 3-month average coming to 301.77K.

Analysts gave the Rockwell Medical Inc (RMTI) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended RMTI as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Rockwell Medical Inc’s EPS for the current quarter is expected to be 0.01.

Rockwell Medical Inc (NASDAQ:RMTI) trade information

Instantly RMTI is in green as seen in intraday trades today. With action 15.71%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 98.36%, with the 5-day performance at 15.71% in the green. However, in the 30-day time frame, Rockwell Medical Inc (NASDAQ:RMTI) is 72.76% up. Looking at the short shares, we see there were 0.43 million shares sold at short interest cover period of 2.35 days.

The consensus price target for the stock as assigned by Wall Street analysts is 9, meaning bulls need an upside of 58.33% from its recent market value. According to analyst projections, RMTI’s forecast low is 9 with 9 as the target high. To hit the forecast high, the stock’s price needs a -140.0% plunge from its current level, while the stock would need to soar -140.0% for it to hit the projected low.

Rockwell Medical Inc (RMTI) estimates and forecasts

Data shows that the Rockwell Medical Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 143.44% over the past 6 months, a 82.35% in annual growth rate that is considerably higher than the industry average of 15.30%. Year-over-year growth is forecast to reach 19.80% up from the last financial year.

Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of 26.5M. 2 analysts are of the opinion that Rockwell Medical Inc’s revenue for the current quarter will be 25.16M. The company’s revenue for the corresponding quarters a year ago was 23.77M and 22.09M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 11.50%. The estimates for the next quarter sales put growth at 13.90%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 44.20%. The 2024 estimates are for Rockwell Medical Inc earnings to increase by 91.67%, but the outlook for the next 5-year period is at 38.00% per year.

Rockwell Medical Inc (NASDAQ:RMTI)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 11.84% of Rockwell Medical Inc shares while 20.77% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 23.56%. There are 20.77% institutions holding the Rockwell Medical Inc stock share, with ARMISTICE CAPITAL, LLC the top institutional holder. As of 2024-06-30, the company held 10.9852% of the shares, roughly 3.22 million RMTI shares worth $5.67 million.

VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 3.8131% or 1.12 million shares worth $1.97 million as of 2024-06-30.